(This is associative evidence and may reflect confounding by indication, surveillance patterns, and glycaemic differences.) For post-marketing pharmacovigilance, FAERS-based analyses of semaglutide identify multiple safety signals (e.g., gastrointestinal obstruction-related terms, dehydration/volume depletion in some GLP-1RA analyses), but vulvovaginal dryness/infection/discharge/pain are not prominent as labelled risks in the major semaglutide FAERS disproportionality paper retrieved here
Your program is designed around your labs, your body composition, and your medical history
The workout you miss when you feel terrible is infinitely better than the injury you sustain by pushing through when your body is compromised
Layne Norton: What's over hyped right now is like
To see if youre a candidate for our personalized programs, we encourage you to take our free assessment quiz to see if you qualify for our prescription weight loss medications